CBLN1 and cancer: It has now been established that the efficacy of many drugs used for cancer chemotherapy exhibit their therapeutic effects through effects on sphingolipid metabolism, in particular through the activation of enzymes that generate the proapoptotic metabolites CER and sphingosine, such as sphingomyelinases [25] and ceramidase [1,4,25,26,27,28,29,30,31].